Epidemiology of liver disease in cystic fibrosis: a longitudinal study

被引:128
作者
Lamireau, T
Monnereau, S
Martin, S
Marcotte, JE
Winnock, M
Alvarez, F
机构
[1] Hop St Justine, Div Pediat Gastroenterol, Montreal, PQ H3T 1C5, Canada
[2] Hosp St Jusitne, Div Pneumol, Montreal, PQ, Canada
[3] Childrens Hosp, Dept Pediat Gastroenterol, Bordeaux, France
[4] INSERM, U593, Bordeaux, France
关键词
cystic fibrosis; cirrhosis; meconium ileus; epidemiology;
D O I
10.1016/j.jhep.2004.08.006
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: To describe the prevalence of liver disease in a cohort of 241 cystic fibrosis (CF) patients. Methods: 241 CF patients were followed-up every 3 months with clinical and biological assessment, and every year with ultrasonography of the liver. The presence of liver disease was studied using a multivariate Cox's regression analysis including variables such as history of meconium Hens, pulmonary function, pancreatic insufficiency and CFTR gene mutations. Results: The prevalence of liver disease was 18, 29, and 41 % after 2, 5 and 12 years, respectively, and did not increase thereafter. In multivariate analysis, the probability of liver disease was independently associated with history of meconium Hens (P = 0.001) and pancreatic insufficiency (P = 0.004). CFTR mutations and severity of pulmonary disease were not associated with liver disease. Cirrhosis occurred in 19 (7.8%) patients at a median age of 10 years, and liver transplantation was required in five patients. Conclusions: This study shows that CF related-liver disease occurs mainly in the first decade of life with a prevalence of 41 % of patients at 12 years of age. A history of meconium Hens and pancreatic insufficiency are predictive of liver disease. Preventive treatment with ursodesoxycholic acid could be considered in patients with meconium Hens. (C) 2004 European Association for the Study of the Liver. Published by Elsevier B.V.. All rights reserved.
引用
收藏
页码:920 / 925
页数:6
相关论文
共 33 条
[21]   The evolution of liver disease in cystic fibrosis [J].
Ling, SC ;
Wilkinson, JD ;
Hollman, AS ;
McColl, J ;
Evans, TJ ;
Paton, JY .
ARCHIVES OF DISEASE IN CHILDHOOD, 1999, 81 (02) :129-132
[22]  
MAURAGE C, 1989, J PEDIATR GASTR NUTR, V9, P17
[23]   Long-term prospective study of the effect of ursodeoxycholic acid on cystic fibrosis-related liver disease [J].
Nousia-Arvanitakis, S ;
Fotoulaki, M ;
Economou, H ;
Xefteri, M ;
Galli-Tsinopoulou, A .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2001, 32 (04) :324-328
[24]   Genotype-phenotype correlation in cystic fibrosis: The role of modifier genes [J].
Salvatore, F ;
Scudiero, O ;
Castaldo, G .
AMERICAN JOURNAL OF MEDICAL GENETICS, 2002, 111 (01) :88-95
[25]   PREVALENCE OF LIVER-DISEASE IN CYSTIC-FIBROSIS [J].
SCOTTJUPP, R ;
LAMA, M ;
TANNER, MS .
ARCHIVES OF DISEASE IN CHILDHOOD, 1991, 66 (06) :698-701
[26]   SERUM BILE-ACID COMPOSITION IN PATIENTS WITH CYSTIC-FIBROSIS [J].
SETCHELL, KDR ;
SMETHURST, P ;
GIUNTA, AM ;
COLOMBO, C .
CLINICA CHIMICA ACTA, 1985, 151 (02) :101-110
[27]   Retrospective review of cystic fibrosis presenting as infantile liver disease [J].
Shapira, R ;
Hadzic, N ;
Francavilla, R ;
Koukulis, G ;
Price, JF ;
Mieli-Vergani, G .
ARCHIVES OF DISEASE IN CHILDHOOD, 1999, 81 (02) :125-128
[28]   Recommendations for management of liver and biliary tract disease in cystic fibrosis [J].
Sokol, RJ ;
Durie, PR .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1999, 28 :S1-S13
[29]   SCLEROSING CHOLANGITIS IN CYSTIC-FIBROSIS [J].
STRANDVIK, B ;
HJELTE, L ;
GABRIELSSON, N ;
GLAUMANN, H .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1988, 23 :121-124
[30]   LIVER-DISEASE IN CYSTIC-FIBROSIS [J].
TANNER, MS ;
TAYLOR, CJ .
ARCHIVES OF DISEASE IN CHILDHOOD, 1995, 72 (04) :281-284